132 related articles for article (PubMed ID: 24140550)
1. Serum N-glycan alteration associated with renal cell carcinoma detected by high throughput glycan analysis.
Hatakeyama S; Amano M; Tobisawa Y; Yoneyama T; Tsuchiya N; Habuchi T; Nishimura S; Ohyama C
J Urol; 2014 Mar; 191(3):805-13. PubMed ID: 24140550
[TBL] [Abstract][Full Text] [Related]
2. O-glycan profiling of serum glycan for potential renal cancer biomarkers.
Gao Y; Ma F; Zhang W; Zhong F; Tang H; Xu D; Zhao L
Sci China Life Sci; 2013 Aug; 56(8):739-44. PubMed ID: 23780530
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis.
Kamiyama T; Yokoo H; Furukawa J; Kurogochi M; Togashi T; Miura N; Nakanishi K; Kamachi H; Kakisaka T; Tsuruga Y; Fujiyoshi M; Taketomi A; Nishimura S; Todo S
Hepatology; 2013 Jun; 57(6):2314-25. PubMed ID: 23322672
[TBL] [Abstract][Full Text] [Related]
4. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of ovarian tumor classification by improved reproducibility in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of serum glycans.
Park CW; Jo Y; Jo EJ
Anal Biochem; 2013 Dec; 443(1):58-65. PubMed ID: 23969014
[TBL] [Abstract][Full Text] [Related]
6. Identification of two new serum protein profiles for renal cell carcinoma.
Engwegen JY; Mehra N; Haanen JB; Schellens JH; Voest EE; Beijnen JH
Oncol Rep; 2009 Aug; 22(2):401-8. PubMed ID: 19578783
[TBL] [Abstract][Full Text] [Related]
7. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
8. Screening for the serum differential proteins of renal cell carcinoma using magnetic beads-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu JS; Li HZ; Zhang YS; Wang P; Yan WG; Xie J; Dong DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Jun; 33(3):287-91. PubMed ID: 21718612
[TBL] [Abstract][Full Text] [Related]
9. Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer.
Ishibashi Y; Tobisawa Y; Hatakeyama S; Ohashi T; Tanaka M; Narita S; Koie T; Habuchi T; Nishimura S; Ohyama C; Yoneyama T
Prostate; 2014 Nov; 74(15):1521-9. PubMed ID: 25154914
[TBL] [Abstract][Full Text] [Related]
10. Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on ClinProt technique.
Chinello C; Gianazza E; Zoppis I; Mainini V; Galbusera C; Picozzi S; Rocco F; Galasso G; Bosari S; Ferrero S; Perego R; Raimondo F; Bianchi C; Pitto M; Signorini S; Brambilla P; Mocarelli P; Galli Kienle M; Magni F
Urology; 2010 Apr; 75(4):842-7. PubMed ID: 19963255
[TBL] [Abstract][Full Text] [Related]
11. Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry.
Hara T; Honda K; Ono M; Naito K; Hirohashi S; Yamada T
J Urol; 2005 Oct; 174(4 Pt 1):1213-7. PubMed ID: 16145372
[TBL] [Abstract][Full Text] [Related]
12. Large-scale glycomics for discovering cancer-associated N-glycans by integrating glycoblotting and mass spectrometry.
Amano M; Nishimura S
Methods Enzymol; 2010; 478():109-25. PubMed ID: 20816476
[TBL] [Abstract][Full Text] [Related]
13. High-throughput quantitative analysis of total N-glycans by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Jeong HJ; Kim YG; Yang YH; Kim BG
Anal Chem; 2012 Apr; 84(7):3453-60. PubMed ID: 22455307
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
[TBL] [Abstract][Full Text] [Related]
15. [Screening urine markers of renal cell carcinoma using SELDI-TOF-MS].
Wu DL; Wang WJ; Guan M; Jin SB; Jin CR; Zhang YF
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1092-5. PubMed ID: 15312509
[TBL] [Abstract][Full Text] [Related]
16. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
17. Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.
Johnson PJ; Poon TC; Hjelm NM; Ho CS; Ho SK; Welby C; Stevenson D; Patel T; Parekh R; Townsend RR
Br J Cancer; 1999 Dec; 81(7):1188-95. PubMed ID: 10584881
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C
PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985
[TBL] [Abstract][Full Text] [Related]
19. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
20. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
